The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic Disorder
- 1 June 1994
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 51 (6), 486-493
- https://doi.org/10.1001/archpsyc.1994.03950060050005
Abstract
From JAMA Psychiatry — The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic DisorderKeywords
This publication has 25 references indexed in Scilit:
- A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorderBiological Psychiatry, 1992
- EVIDENCE OF ENHANCED SENSITIVITY FOR PENTAGASTRIN IN PANIC DISORDER PATIENTSClinical Neuropharmacology, 1992
- Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the ratEuropean Journal of Pharmacology, 1991
- Cholecystokinin-4 and PanicArchives of General Psychiatry, 1990
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- Cholecystokinin and gastrin antagonistsMedicinal Research Reviews, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Classification and function of CCK receptorsTrends in Pharmacological Sciences, 1987
- Two brain cholecystokinin receptors: implications for behavioral actionsBrain Research, 1986
- Cholecystokinins in the central nervous system and neurohypophysisPeptides, 1981